ENTITY
Sun Pharmaceutical Industries

Sun Pharmaceutical Industries (SUNP IN)

220
Analysis
Health CareIndia
Sun Pharmaceutical Industries Limited manufactures and markets pharmaceuticals for domestic and international distribution. The Company's pharmaceutical portfolio includes drugs in the areas of diabetes, cardiology, neurology, psychiatry and gastroenterology.
more
12 Mar 2025 07:31Broker

Sun Pharmaceutical Industries: Checkpoint Acquisition to Strengthen Specialty Business.

Sun Pharma (SUNP) and Checkpoint Therapeutics Inc (Checkpoint) have entered into an agreement under which SUNP will acquire Checkpoint, an...

Logo
274 Views
Share
11 Mar 2025 02:42Broker

Sun Pharmaceutical Industries: Checkpoint Acquisition to Strengthen Specialty Business

Sun Pharma (SUNP) and Checkpoint Therapeutics Inc (Checkpoint) have entered into an agreement under which SUNP will acquire Checkpoint, an...

Logo
275 Views
Share
30 Jan 2025 06:43Broker

Sun Pharmaceutical Industries: Specialty and Domestic Formulation to Drive Growth.

Sun Pharma (SUNP) is expected to sustain steady growth momentum, driven by strong traction in its global specialty business (18% of sales)

Logo
335 Views
Share
23 Jan 2025 09:39Broker

Sun Pharma - Addressing the Oral IL-23 Antagonist Challenge to Ilumya

Emkay Global Financial's research report on Sun Pharma J&J, in a recent investor interaction, had stated that its oral IL-23 receptor antagonist...

Logo
Emkay
201 Views
Share
14 May 2025 19:34Broker

Pharmaceuticals: US to cut Rx drug price, no impact on generics

The US president Donald Trump signed an “Executive Order” (EO) to bring the prices for prescription (Rx) drugs in line with other developed nations

Logo
123 Views
Share
x